Victory Capital Management Inc. Sells 5,941 Shares of Chemed Co. (NYSE:CHE)

Victory Capital Management Inc. lessened its stake in Chemed Co. (NYSE:CHE) by 25.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,417 shares of the company’s stock after selling 5,941 shares during the period. Victory Capital Management Inc. owned approximately 0.12% of Chemed worth $10,467,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in CHE. O Shaughnessy Asset Management LLC increased its position in Chemed by 7.4% during the first quarter. O Shaughnessy Asset Management LLC now owns 2,641 shares of the company’s stock valued at $1,695,000 after acquiring an additional 183 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Chemed by 1.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 10,325 shares of the company’s stock worth $6,629,000 after buying an additional 169 shares during the last quarter. EntryPoint Capital LLC boosted its holdings in shares of Chemed by 14.0% in the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after buying an additional 18 shares during the last quarter. CreativeOne Wealth LLC bought a new stake in Chemed during the first quarter valued at approximately $216,000. Finally, Advisors Asset Management Inc. increased its holdings in Chemed by 12.3% during the first quarter. Advisors Asset Management Inc. now owns 4,649 shares of the company’s stock valued at $2,984,000 after buying an additional 510 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Chemed news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. This trade represents a 1.89 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,113 shares of company stock worth $2,411,905. 3.32% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada dropped their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Chemed Stock Up 1.2 %

NYSE CHE opened at $553.77 on Thursday. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62. The company has a market capitalization of $8.33 billion, a P/E ratio of 27.98, a price-to-earnings-growth ratio of 2.37 and a beta of 0.46. The stock’s 50-day moving average price is $579.26 and its 200-day moving average price is $565.17.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.32 earnings per share. Research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.36%. The ex-dividend date is Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.